LAMA5 and cancer: However, genome-scale CRISPR-Cas9 knockout screens showed that LAMA5 depletion resulted in nearly zero in almost all types of cancers, suggesting LAMA5 was not required for tumor cell survival (Supplementary Fig. S10C).